NEUROPACE INC. - COMMON STOCK

NeuroPace Reports Fourth Quarter & Full Year 2021 Financial Results

10 Mar 2022 16:02:00 By Nasdaq GlobeNewswire

NeuroPace to Report Fourth Quarter and Full Year 2021 Financial Results and Present at the 11th Annual SVB Leerink Global Healthcare Conference 

27 Jan 2022 16:03:00 By Nasdaq GlobeNewswire

NeuroPace Announces Preliminary Unaudited Fourth Quarter and Full-Year 2021 Revenue

11 Jan 2022 16:03:00 By Nasdaq GlobeNewswire

NeuroPace to Present at 40th Annual J.P. Morgan Healthcare Conference

16 Dec 2021 07:00:00 By Nasdaq GlobeNewswire

NeuroPace Reports Third Quarter 2021 Financial Results

10 Nov 2021 16:03:00 By Nasdaq GlobeNewswire

NeuroPace Receives IDE Approval to Initiate NAUTILUS Pivotal Study of its RNS System for Idiopathic Generalized Epilepsy

10 Nov 2021 16:02:00 By Nasdaq GlobeNewswire

NeuroPace to Report Third Quarter 2021 Financial Results on November 10, 2021

20 Oct 2021 16:05:00 By Nasdaq GlobeNewswire

NeuroPace Announces Addition of Lisa Andrade to the Board

19 Oct 2021 16:03:00 By Nasdaq GlobeNewswire

NeuroPace to Participate in Upcoming Conferences

23 Aug 2021 16:03:00 By Nasdaq GlobeNewswire

NeuroPace Reports Second Quarter 2021 Financial Results

12 Aug 2021 16:03:00 By Nasdaq GlobeNewswire

NeuroPace To Report Second Quarter 2021 Financial Results on August 12, 2021

22 Jul 2021 16:03:00 By Nasdaq GlobeNewswire

NeuroPace Awarded Five-Year NIH Grant Funding of More than $9M to Study RNS System in Patients with Lennox-Gastaut Syndrome

30 Jun 2021 08:00:00 By Nasdaq GlobeNewswire

NeuroPace Reports First Quarter 2021 Financial Results and Provides 2021 Financial Guidance

03 Jun 2021 07:00:00 By Nasdaq GlobeNewswire

NeuroPace To Report First Quarter 2021 Financial Results on June 3, 2021

20 May 2021 08:00:01 By Nasdaq GlobeNewswire

NeuroPace, Inc. Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares

26 Apr 2021 16:05:00 By Nasdaq GlobeNewswire